Item 8.01 Other Events
Changes in AGM details
On December 8, 2022, KPMG LLP (“KPMG”),
which had been serving as the independent registered public accounting firm of InMed Pharmaceuticals Inc. (“we,” “us”
or “our”), declined to stand for reelection and resigned as our independent registered public accounting firm, effective immediately.
The audit committee of our board of directors accepted KMPG’s resignation.
While the Company intended
to re-appoint the KPMG at the upcoming Meeting, it now wishes to amend the appointment of auditor resolution provided for in the Management
Information Circular dated October 28, 2021 (the “Circular”), and to recommend the appointment of Marcum.
The Circular has been
mailed to shareholders and is available for viewing on SEDAR. Except as described above, the Circular remains unchanged from the version
that was mailed to the shareholders of the Company and previously filed on SEDAR.
The Circular and Form
of Proxy previously distributed to registered shareholders in connection with the Meeting confers discretionary authority upon management
(or other person designated as proxy therein) to vote on amendments or variations of matters coming before the Meeting. Management intends
to rely on the discretionary authority granted in the Circular and form of proxy to vote FOR the appointment of Marcum as the Company’s
auditor.
If a registered shareholder
has submitted a management proxy and does not wish the proxy to be voted in this manner, they may revoke their proxy at any time prior
to using it: (a) by depositing an instrument in writing, including another completed form of proxy, executed by such registered shareholder
or by his, her or its attorney authorized in writing or by electronic signature; or (b) by transmitting by facsimile or electronic means,
a revocation signed, subject to the Business Corporations Act (British Columbia), by electronic signature, delivered to the Proxy Department,
Computershare Investor Services Inc., 100 University Avenue, 9th Floor, Toronto, Ontario, M5J 2Y1, or to the address of the office of
InMed at Suite 310 – 815 West Hastings St., Vancouver, British Columbia, V6C 1B4, at any time prior to 2:00 p.m. (PST)
on the last business day preceding the day of the Meeting or any adjournment or postponement thereof; or (c) by personally attending the
Meeting and voting the registered shareholders’ common shares; or (d) in any other manner permitted by law.
If a non-registered or
beneficial shareholder wishes to revoke their previously given voting instructions, they must contact the broker or other intermediary
to whom they provided their voting instruction forms and comply with any and all applicable requirements of such broker or intermediary.
A broker or other intermediary may not be able to revoke voting instructions if it receives insufficient notice of revocation, and any
non-registered shareholder wishing to revoke their voting instructions should contact such broker or intermediary in sufficient time to
ensure that their revocation of voting instructions is received.
If as a registered shareholder
you use your control number to access the Meeting and you accept the terms and conditions, you will be revoking any and all previously
submitted proxies for the Meeting and will be provided with the opportunity to vote by online ballot on the matters put forth at the Meeting.
If you have any questions
about any of the information in the Circular or this press release or require assistance in completing your form of proxy or voting instruction
form, please consult your financial, legal, tax and other professional advisors or the Company’s strategic shareholder advisor and
proxy solicitation agent, Computershare, by telephone at 1-866-732-VOTE (8683) (toll-free in North America) or at +1-312-588-4290 outside
of North America, or by the internet at www.investorvote.com.